VNRX - VolitionRX Limited Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.46 -0.01 (-1.34%)	---	---	0.0 (0.0%)	-0.01 (-1.34%)	-0.03 (-5.38%)	0.0 (-0.9%)	-0.01 (-1.32%)

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Category: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Market Period: PreMarket

Earnings & Ratios

Basic EPS:
Diluted EPS:: -0.06
Basic P/E:
Diluted P/E:: -7.485
RSI(14) 1m:: 0.0
VWAP:: 0.45
RVol:: 0.0386

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.47 -0.01 (-1.22%)	Oct 15 16:19
1m	Price decrease 1m	0.47 -0.01 (-1.22%)	Oct 15 16:19
1m	Price decrease 1m	0.47 -0.01 (-1.22%)	Oct 15 16:19
1m	Price decrease 1m	0.47 -0.01 (-1.22%)	Oct 15 16:19
1m	Price decrease 1m	0.47 -0.01 (-1.22%)	Oct 15 16:19